1Eble JN,Sauter G,Epstein JI,et al.World Health Organization classification of tumors.Pathology and Genetics.Tumors of the urynary system and male genital organs[M].Lyon:IARC Press,2004.115-116. 被引量：1
2Parisi T,Yuan TL,Faust AM,et al.Selective requirements for E2F3in the development and tumorigenicity of Rb deficient chimeric tissues[J].Mol Cell Biol,2007,27(6):2283-2293. 被引量：1
3Zacharatos P,Kotsinas A,Evangelou K,et al.Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas[J].Pathol,2004,203(3):744-753. 被引量：1
4Tomita N,Kim JY,Gibbons GH,et al.Gene therapy with E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thyl glomerulonephrifis[J].Int J Mol Med,2004,13(5):629-636. 被引量：1
5Bahnassi AA,Zekri AR,El-Houssini S,et al.Hepatitis C virus-NS3P in relation to p53,p21 war,mdm2,p21-ras and c-erbB2 in hepatocarcinogenesis[J].Gastroenteret Hepatol,2005,20(11):1731-1740. 被引量：1
6Rotterud R,BernerA,Holm R,et al.p53,p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder[J].BJU Int,2001,88(3):202-208. 被引量：1
7Laederich MB, Horton WA. FGFR3 targeting strategies for achon- droplasia[ J ]. Expert Rev Mol Med,2012,14 : el 1. 被引量：1
8Simon R, Burger H, Sernjonow A, et al. Patterns of chromosomal imbalances in muscle invasive bladder cancer [ J ]. Int J Oncol, 2000,17 : 1025 - 1029. 被引量：1
9Foldynova - Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting:the current understanding of fibroblast ~rowth factor re- ceptor 3 ( FGFR3 ) signaling in skeletal [ J ]. Human Mutation, 2012,33(1) :29 -41. 被引量：1
10Palaiologou M, Koskinas J, Karanikolas M, et al. E2F - 1 is overex- pressed and pro - apoptotic in human hepatocellular carcinoma [ J ]. Virchows Arch,2012,460 ( 5 ) :439 - 446. 被引量：1
